Corxel Pharmaceuticals announced it is searching for a new Chief Executive Officer as it prepares for a business combination with Amanat Acquisition Corp. The new CEO is expected to be hired prior to or upon the closing of the transaction, which will make Corxel a wholly owned subsidiary of the combined public company.
Who to call at Corxel Pharmaceuticals, and when
A new leader at Corxel Pharmaceuticals brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Corxel Pharmaceuticals raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Corxel Pharmaceuticals, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Corxel Pharmaceuticals. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Corxel Pharmaceuticals
Location
Berkeley Heights, New Jersey, United States
About
Corxel Pharmaceuticals is a biotechnology company focused on developing innovative therapies for obesity and cardiometabolic diseases. The company is advancing its lead oral GLP-1 medication, CX11, which is in mid-stage testing for obese and overweight patients. Founded in 2019, Corxel has gained rights to several development programs from various pharmaceutical partners. The company aims to provide differentiated treatment options comparable to existing therapies.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Corxel Pharmaceuticals changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.